| 1 | FCRL1, FCRL2, FCRL3, FCRL4, FCRL5
|
| Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia.
|
| Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifian RA, Razavi SM, Jeddi-Tehrani M, Rabbani H, Shokri F.
|
| Int J Cancer 123(9):2113-9. 2008
|
| 2 | FCRL2
|
| FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
|
| Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N, Davis RS.
|
| Blood 112(1):179-87. Epub 2008 Feb 26. 2008
|
| 3 | FCRL2
|
| Cloning and characterization of the human FCRL2 gene.
|
| Chikaev NA, Bykova EA, Najakshin AM, Mechetina LV, Volkova OY, Peklo MM, Shevelev AY, Vlasik TN, Roesch A, Vogt T, Taranin AV.
|
| Genomics 85(2):264-72. 2005
|
| 4 | FCRL1, FCRL2, FCRL3, FCRL4, FCRL5, IRTA5
|
| IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells.
|
| Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R.
|
| Blood 99(8):2662-9. 2002
|
| 5 | FCRL2
|
| Molecular cloning and characterization of SPAP1, an inhibitory receptor.
|
| Xu MJ, Zhao R, Zhao ZJ.
|
| Biochem Biophys Res Commun 280(3):768-75. 2001
|